Psych Congress October 1 - 2024 Supporting materials POSTER: CT-152, a Prescription Digital Therapeutic for Major Depressive Disorder: A Real-World Analysis of Durability of Treatment Effect POSTER: Relative Efficacy and Safety of Adjunctive CT-152 in Patients with Major Depressive Disorder (MDD): Systematic Review and Network Meta-Analysis POSTER: Safety and Efficacy of Aripiprazole Once-Monthly Maintenance Treatment in Black/African American Adults Diagnosed With Bipolar I Disorder: A Post-hoc Analysis of Data From a 52 Week, Open-Label Study POSTER: A Prescription Digital Therapeutic, CT-152, for Treating Major Depressive Disorder: Effectiveness and Safety Results of the Mirai Randomized Controlled Trial POSTER: Comparative Efficacy and Safety of Adjunctive CT-152 in Patients with Major Depressive Disorder: A Network Meta-Regression POSTER: Adherence and Engagement Metrics With the Novel Prescription Digital Therapeutic, CT-152 POSTER: Emotional Faces Memory Task Performance and Clinical Outcomes for the Novel Prescription Digital Therapeutic, CT-152 POSTER: A Qualitative, Interview-based Study of Patient, Caregiver, and Prescriber Preferences for a Long-acting Injectable Antipsychotic Formulation Administered Once Every 2 Months for Schizophrenia or Bipolar I Disorder POSTER: The Impact of Aripiprazole Once-Monthly Initiation and Persistence on Concomitant Psychiatric Medications in Adults Diagnosed With Bipolar I Disorder: A Retrospective Analysis of Claims Data From the United States POSTER: The Effect of Early Initiation of Aripiprazole Once-Monthly 400 mg on Healthcare Resource Utilization and Healthcare Costs in Patients Diagnosed with Bipolar I Disorder: Real-World Evidence from US Claims Data POSTER: Efficacy and Safety of Once-Daily Extended-Release Centanafadine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients POSTER: Efficacy and Safety of Sustained-Release Centanafadine for the Treatment of ADHD in Adults: A Pooled Analysis of Two Phase 3 Trials POSTER: Effect of Centanafadine on AISRS Over 6 Weeks of Treatment in Adults with ADHD: A Pooled Analysis of Two Phase 3 Trials POSTER: Matching-adjusted Indirect Comparison of Treatments for Attention-Deficit/Hyperactivity Disorder in Pediatric Patients: A Focus on Short-Term Outcomes POSTER: Improvement in Caregiver-Rated Executive Functioning Following Centanafadine Treatment in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder POSTER: Clinical and Patient Global Impressions of Improvement Following Centanafadine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients POSTER: Impact of Centanafadine on Conners 3 Inattention and Hyperactivity/Impulsivity Content Scales in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder POSTER: Efficacy of Centanafadine on the Conners 3–Learning Problems Content Scale in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder
